N-terminal inhibition of HSP90 with either geldanamycin or AUY922 increased FN expression, while AUY922 reduced FN secretion in prostate cancer which was linked to a reduction in invasion and migration [37]. The gene discussed is FN1; the disease is prostate cancer.